These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24693334)

  • 41. Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release.
    Xiao B; Tian X; Xie W; Jones PP; Cai S; Wang X; Jiang D; Kong H; Zhang L; Chen K; Walsh MP; Cheng H; Chen SR
    J Biol Chem; 2007 Oct; 282(41):30256-64. PubMed ID: 17693412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy.
    Fauconnier J; Thireau J; Reiken S; Cassan C; Richard S; Matecki S; Marks AR; Lacampagne A
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1559-64. PubMed ID: 20080623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calstabin deficiency, ryanodine receptors, and sudden cardiac death.
    Lehnart SE; Wehrens XH; Marks AR
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1267-79. PubMed ID: 15336974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
    Yildirim SS; Akman D; Catalucci D; Turan B
    Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
    Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
    Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.
    Terentyev D; Györke I; Belevych AE; Terentyeva R; Sridhar A; Nishijima Y; de Blanco EC; Khanna S; Sen CK; Cardounel AJ; Carnes CA; Györke S
    Circ Res; 2008 Dec; 103(12):1466-72. PubMed ID: 19008475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor.
    Doi M; Yano M; Kobayashi S; Kohno M; Tokuhisa T; Okuda S; Suetsugu M; Hisamatsu Y; Ohkusa T; Kohno M; Matsuzaki M
    Circulation; 2002 Mar; 105(11):1374-9. PubMed ID: 11901051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of PKA-mediated phosphorylation of ryanodine receptor on SR Ca
    Bovo E; Huke S; Blatter LA; Zima AV
    J Mol Cell Cardiol; 2017 Mar; 104():9-16. PubMed ID: 28131630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure?
    Fauconnier J; Lacampagne A; Rauzier JM; Vassort G; Richard S
    Cardiovasc Res; 2005 Nov; 68(2):204-12. PubMed ID: 16083867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ryanodine receptor sensitivity governs the stability and synchrony of local calcium release during cardiac excitation-contraction coupling.
    Wescott AP; Jafri MS; Lederer WJ; Williams GS
    J Mol Cell Cardiol; 2016 Mar; 92():82-92. PubMed ID: 26827896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.
    Gonzalez DR; Beigi F; Treuer AV; Hare JM
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20612-7. PubMed ID: 18077344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.
    Sarma S; Li N; van Oort RJ; Reynolds C; Skapura DG; Wehrens XH
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13165-70. PubMed ID: 20615971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance.
    Dixit SS; Wang T; Manzano EJ; Yoo S; Lee J; Chiang DY; Ryan N; Respress JL; Yechoor VK; Wehrens XH
    PLoS One; 2013; 8(3):e58655. PubMed ID: 23516528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FKBP12 activates the cardiac ryanodine receptor Ca2+-release channel and is antagonised by FKBP12.6.
    Galfré E; Pitt SJ; Venturi E; Sitsapesan M; Zaccai NR; Tsaneva-Atanasova K; O'Neill S; Sitsapesan R
    PLoS One; 2012; 7(2):e31956. PubMed ID: 22363773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CaMKII inhibition has dual effects on spontaneous Ca
    Sadredini M; Haugsten Hansen M; Frisk M; Louch WE; Lehnart SE; Sjaastad I; Stokke MK
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H446-H460. PubMed ID: 34270372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required.
    Venetucci LA; Trafford AW; Eisner DA
    Circ Res; 2007 Jan; 100(1):105-11. PubMed ID: 17110597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes-related defects in sarcoplasmic Ca2+ release are prevented by inactivation of G(alpha)11 and G(alpha)q in murine cardiomyocytes.
    Hoyer DP; Grönke S; Frank KF; Addicks K; Wettschureck N; Offermanns S; Erdmann E; Reuter H
    Mol Cell Biochem; 2010 Aug; 341(1-2):235-44. PubMed ID: 20372981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats.
    Fiordaliso F; Bianchi R; Staszewsky L; Cuccovillo I; Doni M; Laragione T; Salio M; Savino C; Melucci S; Santangelo F; Scanziani E; Masson S; Ghezzi P; Latini R
    J Mol Cell Cardiol; 2004 Nov; 37(5):959-68. PubMed ID: 15522273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats.
    Lee TI; Chen YC; Lin YK; Chung CC; Lu YY; Kao YH; Chen YJ
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.